Letter: Further Considerations on the Clinical Use of the Scottish Inflammatory Prognostic Score in STEMI No-Reflow Prediction

Abstract

Get full access to this article

View all access options for this article.

References

Aydın

Murat

Association of the Scottish Inflammatory Prognostic Score with the no-reflow phenomenon in patients with ST-segment elevation myocardial infarction. Angiology. 2026. doi:10.1177/00033197261448371

Esenboğa

Kurtul

Yamantürk

Tan

Tutar

DE.

Systemic immune-inflammation index predicts no-reflow phenomenon after primary percutaneous coronary intervention. Acta Cardiol. 2022;77(1):59-65.

Çelik

Karayiğit

Ozkan

Dolu

Kalçık

Relationship between systemic inflammation index and no-reflow phenomenon in patients with ST-segment elevation myocardial infarction. Angiology. 2023;74(4):387-394.

Pencina

D’Agostino

Sr D’Agostino

Jr Vasan

RS.

Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27(2):157-172.

Vickers

Elkin

EB.

Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making. 2006;26(6):565-574.

Collins

Reitsma

Altman

Moons

KG.

Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): the TRIPOD statement. Ann Intern Med. 2015;162(1):55-63.